Optimising the formulation of orodispersible minitablets for paediatric/geriatric use with isomalt
Dr Michael Black
TOPIC: Raw materials/excipients, patient centricity, manufacturing
Converting innovation into real products with win-win industry partnerships
Andrea Sentimenti
TOPIC: Primary packaging
To overcome challenges during solubility enhancement for poorly soluble drugs
Shilpa Mistry
TOPIC: Solubility Issues
On-dose authentication technology: Deterring counterfeiters and improving patient engagement
Dr Ali Rajab-Siahboomi
TOPIC: Anti-counterfeiting, patient centricity, tablet coating
A quick guide to dry powder inhaler (DPI) testing
Anna Sipitanou
TOPIC: Powder handling, formulation
In-particle design® – mSAS® applications for the accelerated development of optimised therapeutics
Paul Thorning
TOPIC: Process optimisation, excipients, manufacturing
From idea to injection: The importance of automation in biomanufacturing solutions
George White
TOPIC: Technology, process optimisation, automation
Continuous solid oral dose manufacturing challenges: An excipient manufacturer’s viewpoint
Sara Fathollahi
TOPIC: Continuous Manufacturing
Enabling the Manufacture of Next-Generation ImplaVax®-Enabled Solid Dose Vaccines
David Hipkiss
TOPIC: Keynote
Innovation in medicine: patient, heal thyself!
Tal Golesworthy
TOPIC: Patient engagement, case study
Investigating the influence of powder flow properties on DPI dosator performance
Jamie Clayton
TOPIC: Technology, process optimisation, excipients, quality control
Transforming the oral solid dosage forms of tomorrow with a continuous powder to coated tablet process: A live demonstration
Dr James Holman
TOPIC: Keynote
User-friendly oral dosage forms for successful drug delivery
Dr Martin Koeberle
TOPIC: Patient-centricity, compliance, formulation
Why digitising your artwork and labelling processes is the secret ingredient to cost and risk management in successful drug delivery
Gurdip Singh
TOPIC: Packaging/labelling, compliance
From preformulation to the clinic: Understanding the drug and mitigating the risk
Florencia Guidali
TOPIC: Topicals, parenterals
Controlled crystallisation of API materials
Dr Matthew Bennett
TOPIC: Particle design, crystallography
Capsule oral dosage form: providing benefits throughout the entire drug product lifecycle
Mahmoud Farag
TOPIC:Capsules, OSD
Accelerating development through integrated drug substance & drug product strategies
Andy Lewis
TOPIC: Drug development
